山东药玻拟定增募不超32.35亿 实控人将变更为国药集团

Core Viewpoint - Shandong Pharmaceutical Glass (600529.SH) announced a plan for a private placement of A-shares to raise up to 3.24 billion yuan, with the funds intended to supplement working capital [1] Group 1: Issuance Details - The total amount to be raised from the private placement is capped at 323,511.88 million yuan, net of issuance costs [1] - The shares will be issued as ordinary shares (A-shares) with a par value of 1.00 yuan each, and the issuance will occur after approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [1] - The pricing benchmark date for the issuance is the date of the board meeting resolution, with the issue price set at 16.25 yuan per share, which is 80% of the average trading price over the previous 20 trading days [2] Group 2: Shareholder Changes - The issuance will involve China International Medical Health Co., Ltd. and Shandong Yaoxin Health Industry Co., Ltd. as the specific subscribers, both subscribing in cash [1][3] - Following the issuance, China International will become the controlling shareholder, with the actual controller changing to the China National Pharmaceutical Group, and the ultimate controller being the State-owned Assets Supervision and Administration Commission of the State Council [3] - Prior to the issuance, the controlling shareholder was Luzhong Investment, with the actual controller being the Yiyuan County Finance Bureau [3] Group 3: Previous Fundraising and Restructuring - The company previously raised 1.87 billion yuan through a private placement of 68,646,366 shares at a price of 27.19 yuan per share, with the net amount after costs being 1.84 billion yuan [4] - There have been ongoing restructuring efforts involving Luzhong Investment, with plans for a change in control that would affect the indirect controlling shareholder [5][6] - The restructuring agreement was terminated due to changes in market conditions and complexities in the involved parties, with no disputes arising from the termination [7]